FDA Denies Remaining Sunscreen TEAs, Offers Primer On GRASE, Resources
This article was originally published in The Tan Sheet
Executive Summary
FDA denies sunscreen TEAS for L'Oreal and Merck & Co., citing data gaps, according to proposed orders. Proponents of launching additional ingredients say the decisions point to continued gridlock in changing FDA’s OTC sunscreen monograph.
You may also be interested in...
Valisure’s Benzene Testing Finds Problems With OTC Sunscreens, Cosmetic Sun Care Products
Independent lab's analysis found benzene levels at “up to three times the conditionally restricted FDA concentration limit of 2 ppm" in 10 Neutrogena sunscreen formulations.
L’Oréal’s Anthelios SX Will Launch Following FDA Approval Of UVA Filter
L'Oréal will introduce Anthelios SX, the first product on the U.S. market containing a sun filter for short UVA wave protection, this fall, the company announced July 24
P&G Restores Volume Growth In Beauty, Grooming After Pricing Run
Procter & Gamble reports strong consumer spending in the US and Europe after a 3% increase in product pricing over the past year. Dragging on fiscal third-quarter results, sales of SK-II in China fell 30% for the January-March period, while lower incidence of cough and cold impacted Health Care performance.